Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Availability: Larger-volume orders are subject to current inventory
Science 313 , 670673 (2006)
176 GLP-1RAs and diseases As a rising star in recent years, GLP-1RAs are not only effective in metabolic diseases but also play a role in non-metabolic disorders, affecting multiple systems including the musculoskeletal, nervous, cardiovascular, and digestive systems, and can even have implications in oncological diseases
Digestive Health: Understanding that semaglutide can affect gastric emptying, we assess any existing gastrointestinal conditions, such as gastroparesis or post-surgical changes, to prevent exacerbation
Supplementary Materials Data Availability Statement NIH All of Us Research Program data is available to individuals at institutions who have a Data Use and Registration Agreement in place and who complete the necessary introductory, regulatory, and access protocols, which are introduced at: The code used to perform analyses conducted in this manuscript is available via GitHub:
Clinical trials remain the gold standard for identifying drug safety issues
